Working… Menu
Trial record 2 of 36 for:    Aurora Nash

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03059446
Recruitment Status : Terminated (This study was terminated early due to lack of efficacy based on the results of Part I of the AURORA study.)
First Posted : February 23, 2017
Last Update Posted : January 13, 2021
Information provided by (Responsible Party):
Tobira Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 5, 2021
Actual Study Completion Date : January 5, 2021